Back to top of page

CCRP Initiative: Countermeasures Against Chemical Threats (CounterACT) Therapeutics Discovery and Early-Stage Development (UG3/UH3 Clinical Trial Not Allowed)

List of Required Information for Application:

1. Applicant's contact information (name, email, phone number, etc.)

2. Project title and abstract

3. Project description, including the objectives, aims, and significance

4. Specific aims for both UG3 and UH3 phases

5. Timeline and milestones for each phase

6. Budget and budget justification

7. Research team members and their roles

8. Previous relevant experience and expertise of the research team

9. Description of the therapeutic target(s) and rationale for their selection

10. Approach and methodology for target validation and lead compound characterization

11. Approach and methodology for candidate optimization and in vivo demonstration

12. Plans for safety and toxicity evaluations

13. Plans for intellectual property protection, technology transfer, and commercialization

14. Plans for collaboration and engagement with relevant stakeholders, if applicable

15. Evaluation plan for assessing the activity and efficacy of the therapeutic candidate

16. Plan for data management and sharing

17. Expected outcomes and deliverables at the end of the funding period

18. Potential challenges and mitigation strategies

19. References and supporting literature

20. Compliance with ethical guidelines and regulations.

Apply Now
Dollar sign symbol

Funding Amount

Clipboard symbol with a small checkmark bottom right

Eligible Applicants

Checkmark

Eligible Activities

Clock symbol

Deadline to Apply

Apply for Funding

88%

Approval rating across all Canadian funding programs

93%

Average time savings to our clients, compared to
businesses that apply for funding in-house
Woman on high chair reading a book in a small room with windows